[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,171,732
  • Shares Outstanding, K 575,832
  • Annual Sales, $ 2,378 M
  • Annual Income, $ 770,950 K
  • EBIT $ 1,588 M
  • EBITDA $ 1,621 M
  • 60-Month Beta 0.43
  • Price/Sales 13.32
  • Price/Cash Flow 11.52
  • Price/Book 3.19

Options Overview Details

View History
  • Implied Volatility 32.94% (-5.15%)
  • Historical Volatility 19.10%
  • IV Percentile 22%
  • IV Rank 19.91%
  • IV High 75.80% on 01/14/26
  • IV Low 22.28% on 06/12/25
  • Expected Move (DTE 11) 1.83 (3.27%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 127
  • Volume Avg (30-Day) 916
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 13,740
  • Open Int (30-Day) 11,478
  • Expected Range 54.04 to 57.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.27
  • Number of Estimates 4
  • High Estimate $1.29
  • Low Estimate $1.26
  • Prior Year $1.14
  • Growth Rate Est. (year over year) +11.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.28 +13.38%
on 05/07/26
56.07 -0.36%
on 05/29/26
+5.43 (+10.77%)
since 05/05/26
3-Month
44.73 +24.90%
on 03/20/26
56.07 -0.36%
on 05/29/26
+10.19 (+22.31%)
since 03/05/26
52-Week
33.37 +67.43%
on 06/09/25
56.07 -0.36%
on 05/29/26
+22.12 (+65.54%)
since 06/05/25

Most Recent Stories

More News
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference...

RPRX : 55.87 (+1.54%)
3 Mid-Cap Stocks We Steer Clear Of

3 Mid-Cap Stocks We Steer Clear Of

RPRX : 55.87 (+1.54%)
GDDY : 84.38 (-0.54%)
AMKR : 64.95 (-12.02%)
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions

Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions

RPRX : 55.87 (+1.54%)
Royalty Pharma to present at upcoming investor conferences

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: BofA...

RPRX : 55.87 (+1.54%)
Royalty Pharma reports first quarter 2026 results

Portfolio Receipts growth of 10% to $925 million; Royalty Receipts growth of 13% Net cash provided by operating activities of $718 million Raised full year 2026 guidance: Portfolio Receipts expected...

RPRX : 55.87 (+1.54%)
What Does Royalty Pharma's Revenue Forecast Say About the Royalty Model Itself?

Barchart Research What to Expect from RPRX Earnings RPRX Generated May 5, 2026 Current Price $50.44 EPS Estimate $$1.22 Consensus Rating Strong Buy Average Move 2.39% What Does Royalty Pharma's Revenue...

RPRX : 55.87 (+1.54%)
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings

Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings

RPRX : 55.87 (+1.54%)
3 Unpopular Stocks We’re Skeptical Of

3 Unpopular Stocks We’re Skeptical Of

RPRX : 55.87 (+1.54%)
CSCO : 121.64 (-6.43%)
MOV : 37.26 (-0.67%)
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the launch of the Royalty Pharma Translational Prize, which recognizes exceptional achievements in translational...

RPRX : 55.87 (+1.54%)
Royalty Pharma Declares Second Quarter 2026 Dividend

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2026 of $0.235 per Class A ordinary...

RPRX : 55.87 (+1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko...

See More

Key Turning Points

3rd Resistance Point 57.14
2nd Resistance Point 56.54
1st Resistance Point 56.20
Last Price 55.87
1st Support Level 55.27
2nd Support Level 54.67
3rd Support Level 54.33

See More

52-Week High 56.07
Last Price 55.87
Fibonacci 61.8% 47.40
Fibonacci 50% 44.72
Fibonacci 38.2% 42.04
52-Week Low 33.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.